York-based Abingdon Health reveals that lateral flow smartphone reader has been granted further patent

In a statement, Abingdon said: “AppDx enables lateral-flow test readout from your pocket, enabled by a smartphone camera, that can be used by any user app. It consists of a software application programming interface (API) accessed as a library which contains algorithms for image processing and deep learning in order to read a lateral-flow test using a smartphone. . A key point of differentiation is that the algorithm may be located on the smartphone, therefore not requiring a Wifi connection or 4G connection. It can also be provided as a web server-based solution.”

Chris Yates, CEO of Abingdon Health plc, commented: “We are pleased to announce the granting of a further patent for our AppDx smartphone lateral flow reader. Given the expected rapid growth in the lateral flow self-test market we believe the use of smartphone apps, such as AppDx, will be critical in allowing widespread adoption of lateral flow rapid-testing. This patent grant underlines Abingdon’s focus on innovation to support its customers and we now look forward to initiating commercial discussions to bring this product to market.”